medigraphic.com
ISSN 2007-3194 (Print)
Órgano de difusión oficial del Instituto Materno Infantil del Estado de México

2012, Number 2

<< Back Next >>

Arch Inv Mat Inf 2012; 4 (2)

Reporte y análisis de casos del síndrome de HELLP en el puerperio

Pérez MDM, Elizalde VVM, Téllez BGE

Language: Spanish
References: 27
Page: 86-94
PDF size: 77.52 Kb.


ABSTRACT

Introduction: The HELLP syndrome complicates 0.2 to 0.6% of pregnancies, pregnancies with preeclampsia 4-14% and 50% pregnancies with preeclampsia. The most common symptom: headache. In the postpartum period presents the first 48 hours. Most have a history of preeclampsia. The laboratory diagnostic criteria are low levels of platelets, AST› 70 U/L, DHL> 600 U/L. The main hematologic complications are bleeding requiring blood transfusion from to CID. Objective: Describe the evolution of a group of patients admitted to the Intensive Care Unit with a diagnosis of induced hypertension pregnancy complicated by HELLP syndrome during the postpartum period at the Hospital of Gynecology and Obstetrics Maternal-Child Institute of the State of Mexico. Study design: Cases series, descriptive, retrospective, transversal and observational. Results: We studied 21 patients, average age 24 ± 4.8 years; 43% with three or more pregnancies, 90.5% had no history of Ehyeh, 100% diagnosed with Ehyeh; 80.9% diagnosed in the puerperium. Headache in 57.1%. Complications occurred in 47.6%; 70% hematologic, 10% liver and kidney, respectively, and 20% cardio. There were no deaths. Conclusions: The main risk factors were age between 22 to 26 years, have three or more pregnancies. No relationship was presented a history of prior Ehyeh pregnant patient had no history of diabetes mellitus. Severe preeclampsia, 76% of patients, which were complicated by HELLP syndrome. HELLP syndrome type one was made in 38.1%, type two, 52.4% and type three in 9.5% of all patients studied. The 57.1% had headache at the time of diagnosis, 52.4% epigastralgia, nausea and vomiting 23.8% and 4.8% visual disturbances. No patient had jaundice. The 47.3% had complications. The most frequent hematologic, anemia in 70%, 100% required blood transfusion. Acute renal failure was present in 10%. Requiring peritoneal dialysis 10%, and 20% hepatic cardiopulmonary.


REFERENCES

  1. Hernández JA, Estrada J. Definición y clasificación de la hipertensión arterial en el embarazo. En: Hernández-Pacheco JA, Estrada Altamirano A, Editores. Diagnóstico y tratamiento de la hipertensión arterial en el embarazo. 1ª ed. México: Editorial Prado; 2009: 184-207.

  2. Ahued JR. Hipertensión arterial y embarazo. En: PAC GO 3. 1ª ed. México: Intersistemas; 2008: 693-735.

  3. Leis MMT, Rodríguez BMR, García LMA. Diagnóstico y tratamiento de la preeclampsia-eclampsia. Colegio Mexicano de Especialistas en Ginecología y Obstetricia, Ginecol Obstet Mex, 2010; 78 (6): S461-S525.

  4. Sibai BM. Stella CL. Diagnosis and management of atypical preeclampsia-eclampsia, Am J Obstet Gynecol, 2009; 200: 481-487.

  5. Martin JN Jr, Rose CH, Briery CM. Understanding and managing HELLP syndrome: the integral role of aggressive glucocorticoids for mother and child, Am J Obstet Gynecol, 2006; 195: 914-934.

  6. Stella CL, Malik KM, Sibai BM. HELLP syndrome: an atypical presentation, Am J Obstet Gynecol, 2008; 198 (5): e6-e8.

  7. Sibai BM, Ramadan MK, Chari RS, Friedman SA. Pregnancies complicated by HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets): subsequent pregnancy outcome and long-term prognosis, Am J Obstet Gynecol, 1995; 172 (1 Pt 1): 125-129.

  8. Van Rijn BB, Hoeks LB, Bots ML, Franx A, Bruinse HW. Outcomes of subsequent pregnancy after first pregnancy with early-onset of preeclampsia, Am J Obstet Gynecol, 2006; 195: 723-728.

  9. Krauss T, Augustin HG, Osmers R, Meden H, Unterhalt M, Kuhn W. Activated protein C resistance and factor V Leiden in patients with hemolysis, elevated liver enzymes, low platelet syndrome, Obstet Gynecol, 1998; 92: 457-460.

  10. Brito B. Síndrome de HELLP y otras microangiopatías. En: Hernández-Pacheco JA, Estrada-Altamirano A. Capítulo 25. Medicina crítica y terapia intensiva en obstetricia. INPER. Intersistemas Editores; 2007: 241-248.

  11. Knox TA, Olans LB. Liver disease in pregnancy, N Engl J Med, 1996; 335 (8): 569-576.

  12. Bornstein E, Barnhard Y, Russell A, Divon MY. HELLP syndrome: a rare, early presentation at 17 weeks of gestation, Obstet Gynecol, 2007; 110 (2 Pt 2): 525-527.

  13. Haddad B, Barton JR, Livingston JC, Chahine R, Sibai BM. Risk factors for adverse maternal outcomes among women with HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome, Am J Obstet Gynecol, 2000; 183: 444-448.

  14. Martin JN Jr, Rinehart B, May WL, Magann EF, Terrone DA, Blake PG. The spectrum of severe preeclampsia; comparative analysis by HELLP syndrome classification, Am J Obstet Gynecol, 1999; 180: 1373-1384.

  15. Waterstone M, Bewley S, Wolfe C. Incidence and predictors of severe obstetric morbidity: case-control study. BMJ 2001; 322: 1089-1092.

  16. Toirac LA, Pascual LV, Torres GY. Síndrome de Weinstein-HELLP, MEDISAN, 2002; 6 (2): 68-79.

  17. Meneses CJ, Figueroa FMR. Síndrome de HELLP. En: Briones JP, Díaz de León P. Preeclampsia-eclampsia. Distribuidora y Editor Mexicana; 2000: 193-210.

  18. Jasiek M, Plonka T, Celewicz Z, Ronin-Walknowska E. Pregnancy, labor and puerperium in patients with HELLP syndrome, Ginekol Pol, 2004; 75 (7): 506-513.

  19. Sibai BM. Diagnosis, controversies, and management of the syndrome of hemolysis, elevated liver enzymes and low platelet, Obstet Gynecol, 2004; 103: 981-991.

  20. González MJ. Puerperio y lactancia. En: González MJ. Obstetricia. Ed. Masson 2006: 347-357.

  21. Martin JN Jr, Blake PG, Perry KG Jr, McCaul JF, Hess LW, Martin RW. The natural history of HELLP syndrome: patterns of disease progression and regression, Am J Obstet Gynecol, 1991; 164: 1500-1509.

  22. Esan K, Moneim T, Page IJ. Postpartum HELLP syndrome after a normotensive pregnancy, Br J Gen Pract, 1997; 47: 441-442.

  23. Sibai BM. The HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets): much ado about nothing? Am J Obstet Gynecol, 1990; 162: 311-316.

  24. Sibai BM, Ramadan MK, Usta I, Salama M, Mercer BM, Friedman SA. Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome), Am J Obstet Gynecol, 1993; 169: 1000-1006.

  25. Sibai BM. Hipertensión. En: Gabbe, Niebyl, Simpson. Obstetricia. Editorial Marbán 2004: 945-1004.

  26. Grisaru-Granovsky S, Halevy T, Eidelman A, Elstein D, Samueloff A. Hypertensive disorders of pregnancy and the small for gestational age neonate: not a simple relationship, Am J Obstet Gynecol, 2007; 196: 335-338.

  27. Kahra K, Draganov B, Sund S, Hoving T. Postpartum renal failure: a complex case with probable coexistence of hemolysis, elevated liver enzymes, low platelet count, and hemolytic uremic syndrome, Obstet Gynecol, 1998; 92: 698-700.




2020     |     www.medigraphic.com